Fortress Biotech, Inc. - 31 Dec 2024 SCHEDULE 13D/A Report for Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value (ATXI)

Filing Manager: Fortress Biotech, Inc.
Reporting Manager: Fortress Biotech, Inc.
Security: Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value
Symbol: ATXI
Shares outstanding: 2,137,841 shares
Disclosed Ownership: 295,022 shares
Ownership: 13.8%
Form type: SCHEDULE 13D/A
Filing time: 03 Jan 2025, 17:50:20 UTC
Date of event: 31 Dec 2024
Next filing: 02 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Fortress Biotech, Inc.	13.8%	295,022	295,022	0	/s/ Lindsay A. Rosenwald	Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer	0001429260